GLP-1) receptor agonists, which are used to treat type 2 diabetes and/or obesity, were linked to vision problems in a small study. Here's what doctors have to say.

Medications that have transformed the treatment of obesity may also help people drink less alcohol, according to new government-funded research.

Alcohol is responsible for a significant portion of global disease and death, contributing to 2.6 million deaths annually. It ...

Between 15% and 20% of U.S. adults over the age of 65 have obstructive sleep apnea (OSA), according to research in the ...

Right now, our state’s most vulnerable populations that rely on Medicare and Medicaid are unable to access anti-obesity ...

A new study suggests that medications that have transformed the treatment of obesity may also help people drink less alcohol.

Chronic pain is a worldwide epidemic that disproportionately affects women. These surgeons have found innovative solutions - ...

One developer of a weight loss medication, clinical-stage biotech Structure Therapeutics ( GPCR 0.16%), was a victim of a ...

Novo Nordisk's sales and profits were both up around 30% last quarter. Its GLP-1 weight loss drug has been a driving force ...

Palatin Technologies, Inc. (AMEX: PTN) Q2 2025 Earnings Call Transcript February 13, 2025 ...

In a world where alcohol claims nearly 178,000 lives annually in the U.S. alone, a glimmer of hope has emerged from an ...

Recognizing obesity as a chronic disease can improve treatment, address complications, and reshape healthcare strategies for ...